Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

Epigenetic changes in blood cells may contribute to alopecia areata.

Alopecia areata involves immune response and gene changes affecting hair loss.

Immune activities and specific genes are important in male pattern baldness.

Early referral to a pediatric rheumatologist and thorough evaluation are crucial for treating complex overlap syndromes effectively.

The AndroCoV Clinical Scoring is a quick, accurate, and free tool for diagnosing COVID-19.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

The screening method effectively predicts psychosis, valproate use is linked to hair loss, and IDEAS is valid for assessing mental disorder disability.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

Azathioprine treatment led to rapid hair regrowth in a woman with alopecia universalis.

A 29-year-old woman with symptoms of both lupus and rheumatoid arthritis improved with specific medications.

Human hair protein modifications could potentially indicate heart disease risk.

Insulin therapy helped a man with autoimmune issues regrow his hair.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Alopecia areata patients have higher IFN-γ and low vitamin D3 levels.

VESALT improves alopecia areata assessment by including non-scalp areas and is reliable and user-friendly.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

Centralized imaging provides more accurate and consistent hair loss measurements in alopecia areata.